Tumor Biology

, Volume 37, Issue 8, pp 10563–10569 | Cite as

Pyruvate dehydrogenase B promoted the growth and migration of the nasopharyngeal carcinoma cells

  • Hongbo Tang
  • Xinggu Luo
  • Juan Li
  • Yi Zhou
  • Yanmei Li
  • Lijuan Song
  • Xiaowen Zhang
  • Tao Chen
Original Article


Metabolism alteration is one of the hallmarks of cancer cells. Although several studies have demonstrated that glycolysis played important roles in the progression of nasopharyngeal carcinoma (NPC), the functions of specific metabolism-associated genes remain largely unknown. In this study, it was found that Pyruvate dehydrogenase B (PDHB), which catalyzed the conversion of pyruvate to Acetyl-CoA, was downregulated in NPC cells. Forced expression of PDHB in NPC cells inhibited cell growth and migration, while knocking down the expression of PDHB promoted the growth, migration, and tumorigenesis of NPC cells. Mechanism study showed that PDHB inhibited ERK signaling and cell growth driven by RasV12. Collectively, our study demonstrated the suppressive roles of PDHB in the progression of NPC, and restoring the function of PDHB might be a promising strategy for NPC therapy.


PDHB NPC Ras Cell growth and migration 



This work was supported by the grants of Chen T. from the Medical Research Foundation of Guangdong Provincial Health and Family Planning Commission (A2015005), the National Natural Science Foundation of China (81402963), and the First Affiliated Hospital of Guangzhou Medical University (the “Young Elite Talents Program” and the “Science and Technology Support Projects”).

Compliance with ethical standards

All procedures performed in this study involving mouse were in accordance with the ethical standards of the hospital.

Conflicts of interest



  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Lourembam DS et al. Evaluation of risk factors for nasopharyngeal carcinoma in a high-risk area of India, the northeastern region. Asian Pac J Cancer Prev. 2015;16(12):4927–35.CrossRefPubMedGoogle Scholar
  3. 3.
    Isobe K et al. Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: distant metastasis and local recurrence. Int J Oncol. 1998;12(5):1183–7.PubMedGoogle Scholar
  4. 4.
    Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134(5):703–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Saunier E, Benelli C, Bortoli S. The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents. Int J Cancer. 2015;138:809–17.CrossRefPubMedGoogle Scholar
  6. 6.
    Kerbey AL, Richardson LJ, Randle PJ. The roles of intrinsic kinase and of kinase/activator protein in the enhanced phosphorylation of pyruvate dehydrogenase complex in starvation. FEBS Lett. 1984;176(1):115–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Goh WQ et al. DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy. Am J Transl Res. 2015;7(6):1140–51.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Sun XR et al. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer. World J Gastroenterol. 2015;21(17):5336–44.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Cai Z et al. A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics. 2010;9(12):2617–28.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Zuo Q et al. The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma. Biomed Pharmacother. 2011;65(3):168–74.CrossRefPubMedGoogle Scholar
  11. 11.
    Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.CrossRefPubMedGoogle Scholar
  12. 12.
    Lo AK et al. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells. J Pathol. 2015. doi: 10.1002/path.4575.Google Scholar
  13. 13.
    Xiao L et al. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy. Oncogene. 2014;33(37):4568–78.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lan YY et al. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9. J Virol. 2012;86(12):6656–67.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Peng C et al. BRD7 suppresses the growth of nasopharyngeal carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways. Mol Cell Biochem. 2007;303(1–2):141–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Li YJ et al. Dasatinib suppresses invasion and induces apoptosis in nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2015;8(7):7818–24.PubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  1. 1.Department of Otolaryngology‑Head and Neck SurgeryFirst Affiliated Hospital of University of South ChinaHengyangChina
  2. 2.State Key Laboratory of Respiratory Disease, Department of Otolaryngology‑Head and Neck SurgeryFirst Affiliated Hospital of Guangzhou Medical UniversityGuangzhouChina

Personalised recommendations